Non-Hodgkin's Lymphoma Clinical Trials in Beijing, Beijing Municipality
9 recruitingBeijing, Beijing Municipality, China
Showing 1–9 of 9 trials
Recruiting
Phase 1
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital9 enrolled1 locationNCT07620314
Recruiting
Phase 1Phase 2
A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies
Non-Hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.40 enrolled1 locationNCT06066203
Recruiting
Phase 1Phase 2
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.40 enrolled3 locationsNCT05623982
Recruiting
Phase 2
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Junshi Bioscience Co., Ltd.180 enrolled1 locationNCT07081022
Recruiting
Phase 1Phase 2
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital30 enrolled2 locationsNCT05554939
Recruiting
Phase 2
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Juventas Cell Therapy Ltd.60 enrolled17 locationsNCT04586478
Recruiting
Phase 1Phase 2
Chidamide Bridging for CAR-T Therapy
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital120 enrolled13 locationsNCT05370547
Recruiting
Phase 1Phase 2
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Hengrui Pharmaceutical Co., Ltd.132 enrolled1 locationNCT06104553
Recruiting
Phase 1Phase 2
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
Hodgkin's LymphomaNon-Hodgkin's Lymphoma
Chinese PLA General Hospital30 enrolled1 locationNCT02259556